| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $534.5M | +14.9% |
| Cost of Revenue | $133.7M | +13.6% |
| Gross Profit | $400.8M | +15.3% |
| R&D Expense | $99.2M | +3.2% |
| SG&A Expense | $311.0M | +6.7% |
| Operating Income | -$9.4M | +76.4% |
| Pre-tax Income | -$10.2M | +76.7% |
| Income Tax | $1.3M | +25.5% |
| Net Income | -$11.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.4M | +36.4% |
| Accounts Receivable | $66.7M | +10.5% |
| Inventory | $78.5M | +4.2% |
| Current Assets | $322.5M | +20.4% |
| Total Assets | $654.2M | +7.4% |
| Current Liabilities | $81.5M | +11.0% |
| Long-term Debt | $61.0M | -1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $57.3M | +369.8% |
| Capital Expenditures | $9.1M | -21.0% |
| Investing Cash Flow | -$14.6M | -148.1% |
| Financing Cash Flow | $1.2M | +132.6% |
| Free Cash Flow | $48.3M | +6381.1% |
| +74.4% |
| EPS (Basic) | -$0.24 | +74.7% |
| EPS (Diluted) | -$0.24 | +74.7% |
| Total Liabilities |
| $162.2M |
| +9.4% |
| Stockholders' Equity | $491.9M | +6.7% |